Latest Lundbeck Stories
Global Schizophrenia Therapeutics Market 2014-2018 is a new industry research report, of 102 Pages profiles key players like AstraZeneca plc, Bristol-Myers Squibb Co., Eli Lilly and Co., F.
LONDON, October 29, 2014 /PRNewswire/ -- More than 170 international policymakers, senior business leaders, academics, and patient advocates, are convening in London on
New comprehensive report “Memantine - Comprehensive patent search” elaborated by Ark Patent Intelligence is now available at MarketPublishers.com. London,
Blockbuster Status Awaits Novel DMTs and Lundbeck/Otsuka's Emerging Symptomatic Agent Lu-AE58054, According to Findings from Decision Resources Group BURLINGTON, Mass., July 21, 2014 /PRNewswire/
MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas,
Data Highlight Physician and Payer Receptivity to Emerging Agents for Treatment-Resistant Depression, According to Findings from Decision Resources Group BURLINGTON, Mass., June 23, 2014 /PRNewswire/
Takeda and Lundbeck Announce Results at American Society of Clinical Psychopharmacology Annual Meeting HOLLYWOOD, Fla., June 17, 2014 /PRNewswire/ -- Takeda Pharmaceuticals Company Limited
Takeda and Lundbeck to Present Late-breaker at International College of Neuropsychopharmacology World Congress VANCOUVER, British Columbia, June 16, 2014 /PRNewswire/ -- Takeda Pharmaceutical
ReportsnReports.com adds “PharmaPoint Major Depressive Disorder - Current and Future Players” to its store.
- To fire mitraille at.